Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring Inflation-Related Public Discourse Relevant to Social Determinants of Health Using Social Media Data.

International journal of environmental research and public health·2026
Same author

Trends in primary surgery and overall survival in non-metastatic anal cancer: a population-based analysis.

The oncologist·2026
Same author

Wedge Resection vs Stereotactic Body Radiation Therapy for Stage 1 Non-Small Cell Lung Cancer in Octogenarians.

Annals of thoracic surgery short reports·2026
Same author

Trends in primary surgery and overall survival in non-metastatic anal cancer: a population-based analysis.

The oncologist·2026
Same author

Predictors of severe immune-related adverse events during first-line immune checkpoint inhibitor therapy for advanced non-small cell lung cancer.

Scientific reports·2026
Same author

Association of Combined Marijuana and Opioid Use with Major Depressive Disorder Among Adults with Chronic Conditions in the United States.

Substance use : research and treatment·2026

Related Experiment Videos

Depression Treatment Patterns among Elderly with Cancer.

Patricia A Findley1, Chan Shen, Usha Sambamoorthi

  • 1School of Social Work, Rutgers University, New Brunswick, NJ 08901, USA.

Depression Research and Treatment
|September 13, 2012
PubMed
Summary

Cancer patients aged 65+ with depression often receive insufficient treatment. Many elderly cancer patients with depression do not receive antidepressants or psychotherapy, highlighting significant care gaps.

Related Experiment Videos

Area of Science:

  • Geriatric Medicine
  • Oncology
  • Psychiatry

Background:

  • Cancer and depression frequently co-occur in the elderly population.
  • Limited research exists on cancer treatment patterns and depression management in older adults.
  • Understanding depression treatment is crucial for comprehensive geriatric cancer care.

Purpose of the Study:

  • To investigate depression treatment patterns among elderly individuals diagnosed with both cancer and depression.
  • To identify factors associated with receiving or not receiving depression treatment in this demographic.
  • To address a gap in the literature regarding geriatric oncology and mental health.

Main Methods:

  • Utilized data from the Medicare Current Beneficiary Survey (MCBS) spanning 2000-2005.
  • Analyzed treatment patterns including antidepressant use (with or without psychotherapy) and no treatment.
  • Examined demographic and clinical factors influencing treatment access.

Main Results:

  • Over half (57.7%) of elderly cancer patients with depression received only antidepressant medication.
  • A smaller proportion (19.7%) received psychotherapy, with or without antidepressants.
  • A significant 22.6% received no depression treatment.
  • Minority race, lower education, rural residency, and higher comorbidity were linked to reduced treatment access.

Conclusions:

  • Disparities exist in depression treatment for elderly cancer patients.
  • Targeted interventions are needed to improve access to mental health services for vulnerable older adults with cancer.
  • Addressing these disparities is essential for improving the quality of life and outcomes in geriatric oncology.